Dr. Haibo Qian
Advisory Board Member at Blue Ocean Capital Group
About
Dr. Haibo Qian joined BOCG's advisory board in May 2024. He holds a Ph.D. in Management and Social Pharmacy from China Pharmaceutical University and serves as a Senior Economist, Research Fellow, and adjunct professor at Nanjing Medical University. From 1994 to May 2023 he held leadership roles at Sinopharm Pharmaceuticals Group, including Vice President and Corporate Secretary of its U.S.-listed company, working across investments, sales, human resources, public affairs, and mergers and acquisitions.
Invests in
Biotech
Colleagues at Blue Ocean Capital Group
Dr Waleed AI-Shaqha
Science & Strategic Advisor at Blue Ocean Capital Group
Dr. Daniel Tang
Venture Partner at Blue Ocean Capital Group
Dr. Duanqing Pei
Chief Scientist Advisor in Cell & Regenerative Medicine at Blue Ocean Capital Group
Dr. Hua Jiang
Senior Industry Advisor at Blue Ocean Capital Group
Dr. Jean Paul Thiery
Senior Advisor at Blue Ocean Capital Group
Dr. Jixi Li
Senior Advisor at Blue Ocean Capital Group
Dr. Min Zhuo
Chief Scientific Advisor for Neuroscience at Blue Ocean Capital Group
Dr. Xinye Xiao
Industry Advisor at Blue Ocean Capital Group